Abstract
Cancer is one of the major causes of death in human beings. While traditional cancer treatments kill cancerous cells, they negatively affect normal cells. In addition, the side effects and high medical costs of treatment prevent effective management of cancer. Nonetheless, anticancer peptides have gained popularity over the recent years as potential therapeutic agents that may complement traditional therapies. Compared to conventional wet-lab experiments, computation-based methods provide a promising platform for high-throughput identification of peptides that have anticancer activity. Therefore, this review summarizes the currently available databases for anticancer peptides/proteins. This is a survey of 22 recently published in-silico methods that aim to predict anticancer peptides accurately. More specifically, the article details the benchmark datasets, feature construction, feature selection, machine learning algorithms, assessment criteria, comparison of different methods, and publicly available predictors. We also compare the prediction performance of these predictors to the benchmark dataset. Finally, the study makes several recommendations concerning the future development of databases for anticancer peptides and methods that can be used to predict anticancer peptides.
Keywords: Anticancer peptide, In-silico, Machine learning, Feature construction, Feature selection, Cancer.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Survey of In-silico Prediction of Anticancer Peptides
Volume: 21 Issue: 15
Author(s): Nan Ye*
Affiliation:
- School of Finance and Economics, Xinyang Agriculture and Forestry University, Xinyang 464000,China
Keywords: Anticancer peptide, In-silico, Machine learning, Feature construction, Feature selection, Cancer.
Abstract: Cancer is one of the major causes of death in human beings. While traditional cancer treatments kill cancerous cells, they negatively affect normal cells. In addition, the side effects and high medical costs of treatment prevent effective management of cancer. Nonetheless, anticancer peptides have gained popularity over the recent years as potential therapeutic agents that may complement traditional therapies. Compared to conventional wet-lab experiments, computation-based methods provide a promising platform for high-throughput identification of peptides that have anticancer activity. Therefore, this review summarizes the currently available databases for anticancer peptides/proteins. This is a survey of 22 recently published in-silico methods that aim to predict anticancer peptides accurately. More specifically, the article details the benchmark datasets, feature construction, feature selection, machine learning algorithms, assessment criteria, comparison of different methods, and publicly available predictors. We also compare the prediction performance of these predictors to the benchmark dataset. Finally, the study makes several recommendations concerning the future development of databases for anticancer peptides and methods that can be used to predict anticancer peptides.
Export Options
About this article
Cite this article as:
Ye Nan *, Survey of In-silico Prediction of Anticancer Peptides, Current Topics in Medicinal Chemistry 2021; 21 (15) . https://dx.doi.org/10.2174/1568026621666210612030536
DOI https://dx.doi.org/10.2174/1568026621666210612030536 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pulmonary Hypertension: Types and Treatments
Current Cardiology Reviews Mesenchymal Stem Cells: Use in Cartilage Repair
Current Rheumatology Reviews Gender Differences in Autonomic Control of the Cardiovascular System
Current Pharmaceutical Design Augmentation Therapy with Alpha1-antitrypsin: Novel Perspectives
Cardiovascular & Hematological Disorders-Drug Targets Colloid Update
Current Pharmaceutical Design Neuropharmacology of Stress-Induced Mucosal Inflammation: Implications for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Current Molecular Medicine Short Radius Centrifuges – A New Approach for Life Science Experiments Under Hyper-g Conditions for Applications in Space and Beyond
Recent Patents on Space Technology T-type Calcium Channels in Health and Disease
Current Medicinal Chemistry Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Current Gene Therapy Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
Current Neuropharmacology Aldosterone Receptor Antagonists and Cardiovascular Disease: Do We Need a Change of the Guard?
Cardiovascular & Hematological Agents in Medicinal Chemistry Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure
Current Vascular Pharmacology Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Current Medicinal Chemistry - Central Nervous System Agents Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
CNS & Neurological Disorders - Drug Targets Super-Resolution Based Enhancement of Cardiac MR Images
Current Medical Imaging Central Hemodynamics for Risk Reduction Strategies: Additive Value Over and Above Brachial Blood Pressure
Current Pharmaceutical Design AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders
Current Topics in Medicinal Chemistry Corticotropin Releasing Factor (CRF) Receptor Signaling in the Central Nervous System: New Molecular Targets
CNS & Neurological Disorders - Drug Targets Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
CNS & Neurological Disorders - Drug Targets